跳至主要内容
临床试验/NCT01389336
NCT01389336已完成不适用

Kontrollierte Klinische Nicht-randomisierte Pilotstudie Zur Komplexen Āyurveda-Therapie Beim Fibromyalgiesyndrom im Vergleich Zur Konventionellen Standardbehandlung

Andreas Michalsen1 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2011年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
31
试验地点
1
主要终点
Fibromyalgia Impact Questionnaire (FIQ)

研究概览

简要总结

The aim of this study is to evaluate the effectiveness of an additive complex āyurvedic diagnosis and treatment compared to conventional standard care alone in stationary patients with Fibromyalgia Syndrome.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • informed consent
  • age between 18 and 70 years
  • FMS according to current guidelines

排除标准

  • change of pharmacological FMS treatment >= 6 weeks before inclusion
  • pregnancy or breat feeding
  • acute psychiatric condition
  • severe acute somatic disease
  • severechronic comorbidity
  • obesity WHO >= II degree
  • bloodcoagulation-disease
  • intake of opiods
  • current treatment with hyperthermia
  • simultaneous participant in other trial
  • praticipation in other trial during 6 month before inclusion

结局指标

主要结局

Fibromyalgia Impact Questionnaire (FIQ)

时间窗: max. 3 weeks

Change in FIQ after completion of IPD-treatment

次要结局

  • Functional Hanover Questionnaire (FFBH)(max. 3 weeks)
  • State Trait Anxiety Inventory (STAI)(max. 3 weeks)
  • Profile of Mood States (POMS)(max. 3 weeks)
  • Short Form 36 Health Survey (SF-36)(max. 3 weeks)
  • VAS for pain(max 3 weeks)
  • Likert-Scales(max 3 weeks)
  • FIQ(6 month)
  • FFBH, STAI, POMS, SF-36, VAS, Likert-Scales.(6 month)

研究者

发起方
Andreas Michalsen
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Andreas Michalsen

Prof. Dr. Andreas Michalsen

Charite University, Berlin, Germany

研究点 (1)

Loading locations...

相似试验